Cytokinetics shares owned by Eventide Asset Management
Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Eventide Asset Management
from 13F filings
Historical chart of Eventide Asset Management investment in Cytokinetics
Tip: Access up to 7 years of quarterly data
All positions including Cytokinetics held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytokinetics by Eventide Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $46M | 556k | 83.49 |
| 2023-09-30 | $16M | 556k | 29.46 |
| 2023-06-30 | $18M | 556k | 32.62 |
| 2023-03-31 | $20M | 556k | 35.19 |
| 2022-12-31 | $26M | 556k | 45.82 |